AI assistant
Sending…
GENETIC TECHNOLOGIES LIMITED — Director's Dealing 2003
Aug 13, 2003
65022_rns_2003-08-13_3c755881-8e81-41f3-8610-43b2d2390b6f.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y
Rule 3.19A.2
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/9/2001.
| Name of entity Genetic Technologies Limited | |
|---|---|
| ABN 17 009 212 328 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Ian Alistair Dennis |
|---|---|
| Date of last notice | 4 January 2002 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Direct or indirect interest | Direct and indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Ian Alistair Dennis and Caroline Dennis as trustees for the lan Dennis Superannuation Fund $-300,000$ ordinary shares |
| Date of change | 12 August 2003 |
| No. of securities held prior to change | 300,000 Ordinary Shares - Ian Dennis Superannuation Fund 1,000,000 Options exercisable at 45 cents on or before 14 April 2005 1,000,000 Options exercisable at 61 cents on or before 30 November 2007 |
| Class | Fully paid ordinary shares and unlisted options |
| Number acquired | 1,000,000 ordinary shares upon exercise of 45 cent options |
| Number disposed | 1,000,000 ordinary shares |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
\$450,000 on exercise of options \$700,000 on sale of shares |
| No. of securities held after change | 300,000 Ordinary Shares - Ian Dennis Superannuation Fund 1,000,000 Unlisted Options exercisable at 61 cents on or before 30 November 2007 |
+ See chapter 19 for defined terms.
Part 2 - Change of director's interests in contracts
| Detail of contract | |
|---|---|
| Nature of interest | |
| Name of registered holder | |
| (if issued securities) | |
| Date of change | |
| No, and class of securities to which interest | |
| related prior to change | |
| Note: Details are only required for a contract in relation to which the interest has changed |
|
| Interest acquired | |
| Interest disposed | |
| Value/Consideration | |
| Note: If consideration is non-cash, provide details and an estimated valuation |
|
| Interest after change | |
Dated at Sydney on 14 August 2003
$+$ See chapter 19 for defined terms.
More from GENETIC TECHNOLOGIES LIMITED
Interim / Quarterly Report
2026
Mar 29
Interim / Quarterly Report
2026
Mar 29
Interim / Quarterly Report
2026
Mar 29
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Board/Management Information
2026
Mar 23
Regulatory Filings
2026
Mar 23
Board/Management Information
2026
Mar 5